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ABSTRACT 
This study investigated the surface of semi-crystalline composite granules produced via a 
novel mechnao-chemical process and assessed the effect of electrostatic charging. Ibuprofen 
(IBU), a model drug with low solubility and know associated processing challenges was 
loaded in composite granules to improve its processibility and dissolution rates. Synthetic 
amorphous mesoporous magnesium alumina metasilicate (MAS) was co-processed with 
hydrophilic HPMC polymer in the presence of polyethylene glycol 2000 (PEG) and deionised 
water. The solid state analyses conducted by scanning electron microscopy (SEM), X-ray 
powder diffraction (XRPD) and differential scanning calorimetry (DSC) revealed the 
existence of semi-crystalline IBU in the complex composite structures. Dynamic vapour 
sorption (DVS) study showed the water sorption and desorption profiles of the manufactured 
composite granules as well as the effect of water on the solid-state stability of IBU in various 
formulations. Advanced surface analysis conducted via energy dispersive X-ray (EDS) 
revealed homogenous distribution of the drug/excipients on the surface of the granules while 
atomic force microscopy (AFM) complemented the findings. The electrostatic charge 
analysis showed variable charge property which is affected by the size of the 
particles/granules. As expected, the in vitro dissolution study showed about 5 fold increase in 
the release rates of IBU compared to that of the bulk drug. The mechanochemical processing 
has been demonstrated as an efficient technique to develop semi-crystalline composite 
granules with enhanced dissolution rates of water insoluble drugs.  
 
Keywords: composite, solubility, amorphous, surface analysis, semi-crystalline, electrostatic 
charging, DVS analysis 
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1. Introduction 
Approximately 40% of the recent medicinal lead compounds met in the discovery 
pipeline are considered hydrophobic that leads to a low dissolution and poor bioavailability 
[1]. Such compounds mainly belong to Biopharmaceutical Classification Systems (BCS) 
class II which are high permeable with limited absorption or solubility. Therefore, the 
dissolution is the rate-limiting step in drug absorption of this class [1, 2].   
The Noyes–Whitney equation reveals a direct link of the increase in dissolution rate 
with that of surface area [3, 4]. Generally, an increase in the surface area occurs when the 
particle size of the drug is reduced thus the dissolution rate is enhanced. Therefore, 
micronisation or reduction of the particle size of drug candidates may prove an efficient 
approach to enhance its dissolution rate. However, in the processing of poorly water-soluble 
drug, many associated challenges may have to be overcome as not only may the solubility of 
the drug influence its bioavailability but also their solid state properties. The solid state 
properties of the drug may be influenced by the way in which they are developed and 
formulated [4-8]. Different complementary pharmaceutical technologies/methods have been 
employed to overcome such processing issues of water insoluble drugs such as the use of 
pharmaceutical grade polymers e.g. poly(ethylene glycol) (PEG) and starch as meltable 
polymer excipients [9]. These polymers alone or when co-processed with other excipients 
may improve the solubility and dissolution profile of the drugs by means of resulting in the 
formation of composites. These composite forming materials ease the preparation and 
processing that are commercially viable and scalable products [9, 10]. In this study, we 
investigate the manufacturing of composite granules that are suitable to process a low melting 
point, sticky, poorly soluble drug.  
Granulation process is highly and most commonly used by the pharmaceutical 
manufacturers to manufacture oral pharmaceutical products. From the outset of the 
pharmaceutical implementation of granulation process, it has mainly been improved using 
contemporary pharmaceutical technologies such as high shear/fluid bed granulations, in batch 
manufacturing mode [11, 12]. During the mechanical granulations process, the manufactured 
granules are prone to triboelectric charging due to the collision of the particles with the 
container walls and with each other [13, 14]. This generated particle charging can cause 
severe problems in the intermediate steps of the pharmaceutical product manufacture by 
affecting powder flow and dose uniformity [15, 16]. Therefore, triboelectrification can be 
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used as a way of manipulating the charge of their final product of the granules manufacture 
via a granulations approach. 
To the best of our knowledge, most of the previously reported studies primarily 
emphasised on the process optimization. None of them reported the granulation technology to 
manufacture composite granules with detailed particle chemistry in order to enhance the 
dissolutions of water insoluble drugs (e.g. ibuprofen). We investigate the effect of both 
formulation composition and the processing techniques on the dissolution rates of a poorly 
water soluble drug with a particular emphasis on the particle chemistry.  Neusilin is an 
amorphous mesoporous magnesium aluminometasilicate (MAS) which has relatively high 
specific surface area (300 m2/g) [17-19]. MAS also exhibits high flowability, mechanical 
stability and thermal properties which helps the API processing to develop dosage forms. On 
the other hand, ibuprofen (IBU) is a nonsteroidal anti-inflammatory drug with a relatively 
low melting temperature (77oC) and poor water solubility. Being difficult to compact IBU has 
a soapy bitter and burning taste and can be used as an ideal candidate to assess processing 
method without compromising the dissolution rates [20].  
In this study, we investigate the composition, processing, and performance properties 
of a model ternary composite system using IBU with known associated formulation 
challenges. The role of MAS as an alternative granulation carrier has also been explored and 
supported with physicochemical characterisation data. A novel triboelectrification strategy 
has also been studied to assess the impact of the particle charging on the performance and 
physical properties of the manufactured composite granules.  
 
2. Materials and methods 
2.1 Materials 
Ibuprofen (IBU) and polyethylene glycol 2000 (PEG) were bought from Sigma-
Aldrich (Gillingham, UK). Neusilin US2 (magnesium aluminometasilicate -MAS) was 
obtained from Fuji Chemical (Japan). Hydrophilic polymeric carrier, hydroxy propyl methyl 
cellulose polymer K4 (HPMC) was obtained from Colorcon Ltd, (Dartford, UK) as a gift. All 
solvents utilised in HPLC were of HPLC grade only while the rest of solvents used were of 
analytical grade. 
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2.2. Preparation of the composite granules 
Various drug/MAS/PEG 2000 compositions (10 g) were mixed thoroughly (Table 1) 
in a mortar and pestle with the slow addition of granulating liquid (20% w/w) prior to mixing 
in a Turbula TF2 mixture (Basel, Switzerland) for 10 min. The granulating liquid used in this 
study is deionised water. The granules were not dried prior to mixing in the Turbula mixer. 
The obtained mixture of drug-loaded formulations were then subject to grinding (Ball Mill, 
Retsch, Germany) at 400 rpm with 8 balls for 5 min followed by granulations using Erweka 
AR403 granulator (Heusenstamm, Germany) with oscillating rotor set at 100 rpm and 0.315 
mm sieve. Physical blends of the drug and excipients were made for comparison purpose 
which were not subject to the mechanochemical processing. All collected composite granules 
were then further sieved manually to obtain an optimum particle size threshold d(50) below 
250 µm. 
2.3 Particle size analysis 
The particle size of all manufactured composite granules was analysed via a laser 
diffraction method (Mastersizer 2000, Malvern Instruments, UK).  Scirocco 2000 as a dry 
powder sample dispersion accessory was integrated with the particle sizer. All samples were 
run in triplicate while pressure was set 2 bars and feed rate at 50%. All data acquisitions, 
interpretations and calculations were undertaken by Mastersizer 2000 software as well as the 
d(50) which is the geometric median particle size and the d(10) and d(90) which are the 
particle diameters at 10% and 90% of the cumulative volume distribution, respectively. The 
span referred to the width of the distribution relative to the d(50) was determined via equation 
1. 
 
2.4 Atomic Force Microscopy (AFM)  
An easyscan 2 (nanosurf, Switzerland) machine was used to take AFM photographs 
on tapping mode by using tap 190Al-G cantilevers (BudgetSensors, Sofia, Bulgaria). The 
intermittent force between the oscillated tip and the substrate were kept to minimum by 
balancing the drive amplitude and the relative set point. SPIP software (Image Metrology, 
Hørsholm, Denmark) was utilised to analyse the images and for the data interpretations. 
)1(][
)50(
)10()90(
d
dd
Span
−
=
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 6 
 
 
2.5 Scanning electron microscopy (SEM)/ energy dispersive X-Ray (EDS) analysis 
SEM images were captured using a cold-cathode field-emission gun scanning electron 
microscope (Hitachi SU8030 FEG-SEM, Japan) and Thermo-Noran (USA) EDX system with 
30 mm2 Ultra-Dry window and Noran 7 software. The samples were glued with a double-
sided carbon adhesive tabs and coated with carbon (Edwards 306 high vacuum carbon 
evaporation) prior to the SEM/EDX analysis. The accelerating voltage was set at 8 kV. 
Principal components were extracted from the X-ray maps using Noran 7 COMPASS 
software. The particle distribution on the surface area was characterized on the basis of 
chemical composition and morphology by using XPhase.  
2.6 X-ray powder diffraction study 
XRPD was used to determine the solid state of bulk materials, physical mixtures and 
the manufactured granules using a Bruker D8 Advance (Germany) in theta-theta mode. For 
the study purposes a Cu anode at 40kV and 40Ma, parallel beam Goebel mirror, 0.2 mm exit 
slit, LynxEye Position Sensitive Detector with 3° opening (LynxIris at 6.5 mm) and sample 
rotation at 15 rpm were used. Each sample was scanned from 2 to 40° 2θ with a step size of 
0.02° 2θ and a counting time of 0.1 seconds per step; 176 channels active on the PSD making 
a total counting time of 35.2 seconds per step.  All diffraction data were analysed via using 
EVA phase analysis software (Bruker, Karlsruhe, Germany) while TOPAS V4.2 structural 
analysis software (Bruker, Karlsruhe, Germany) was used to determine the amorphous 
content of the ibuprofen in the composite granules. Cambridge structural database (CSD) 
(REFCODE: JEKNOC10) was utilised to retrieve the crystal structure data of ibuprofen 
which was used as a standard to compare and contrast with those in our samples. The 
percentage amorphous content in the formulations is calculated via scaling the peaks of 
crystalline drug to the standard and redistributing the rest.  
 
2.7 Differential scanning calorimetry (DSC) study 
A Mettler Totledo 823e DSC machine (Greifensee, Switzerland) was utilised to study 
the solid state of the bulk drug, excipients, physical blends and the composite granules. In 
order to evaluate the thermal transitions, about 3-5 mg of each sample was accuratley 
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weighed in an aluminium pan with pierced lid and heated from 0oC to 200oC at a constant 
heating rate of 10o/min. During the whole experiments, an inert environment by using 
nitrogen gas was maintained. All samples were run in triplicates and the results showed 
present the means of all three scans.  
2.8 DVS analysis 
Water sorption and desorption of the semi-crystalline composite IBU granules was 
determined via a dynamic vapour sorption (DVS) analyser, Advantage-1 (SMS, UK). Being 
equilibrated at 0% RH for 5 min all sample’s dry and reference mass prior was recorded to 
the exposition of the samples to the following relative humidity (% RH) profile: 0 to 100% in 
20% steps and the reverse for desorption at 25.0±0.1°C and 40±0.1°C. At each stage, prior to 
the change of the humidity, the sample mass was allowed to reach equilibrium, defined as 
dm/dt=0.002 mg/min over 10 min, before the RH was changed. A total gas flow 200 sccm 
was maintained throughout the study. The amount of water uptake was calculated as 
percentage of weight change compared to the dry initial mass. 
2.9 Electrostatic charge analysis 
Bipolar charge characterisation of particulates was obtained by using novel sensing 
method recently developed in the Wolfson Centre Fig 1a [21]. The method based on a single 
non-intrusive, non-contact electrostatic inductive sensor (ring probe), charge amplifier unit, 
national instrument data acquisition hardware and personal computer to visualise, record, and 
process charge signal to extract information of interest and vibratory orifice feeder. A typical 
charged signal for the F3 is shown in Fig. 1b.  
Charged particulate was mounted on a vibratory orifice feeder and fed into the sensor 
under gravity. Due to non-homogeneous sensitivity distribution, the sensor is 7% more 
sensitive for particles travelling under peripheral flow stream compared to those under central 
flow stream. It was assumed that all particles were moving under central flow stream in order 
to minimise the influence of non-homogeneous sensitivity distribution. Evaluation studies 
reported previously clearly indicated the advantages of this method for providing a better 
understanding of bipolar charge and charge distribution in particulates [22, 23]. All 
experimental works were carried out inside in a walk-in chamber where the relative humidity 
(55% RH) temperature (ambient) can be controlled. 
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2.10 In vitro dissolution study 
The dissolution studies were performed using Varian 705 DS. The temperature of the 
dissolution bath was maintained at 37oC and the stirring rate at 100 rpm. The dissolution 
medium used was 900 mL 0.1 N HCl solution of pH 1.2 for 2 h. The granules of about 200 
mg equivalent of IBU was used in each vessel. About 2-3 ml samples were withdrawn at an 
interval of 15 min, 0.5, 1, 2 h and filtered prior to collect them in airtight glass vials. 
2.11 HPLC analysis  
The release of IBU from the composite granules was determined by using HPLC, 
Agilent Technologies system 1200 series. A HYCHROME S50DS2-4889 (5 µm x 150 mm x 
4.6 mm) column, wavelength set at 214 nm and a mobile phase consisting of 
acetonitrile/water/phosphoric acid (65/35/0.2 v/v) were used for the HPLC analysis. During 
the entire analysis, flow rate was maintained at 1.5 ml/min. A calibration curve was prepared 
with concentrations varying from 10 µg /ml to 50 µg/ml and 20 µl injection volumes. 
 
3. Results and discussion 
3.1 Particle size and morphology 
The results obtained from the particle size analysis indicated that either a monomodal 
or bimodal shape with an average low span values between 1.5 and 3.3 (Fig. 2a and Table 1) 
represented the volume distributions of the manufactured composite granules. The d(50), 
d(10) and d(90) values are also summarised in Table 1. As it can be seen from the table that 
the d50 was from 97±0.17 µm to 150±0.20 µm while the d(90) was 246.60±0.35 - 
286.40±0.26 µm. The calculated specific surface area (SSA) via Mastersizer 2000 for all 
granules was in the range of 0.06±0.09-0.10±0.08 m2/g due to the optimised granules size in 
all formulations. The formulation composition especially the excipient/polymer ratios seemed 
to play a pivotal role to affect the d(50) values of all granules. Interestingly, the equal amount 
of MAS polymer in formulation F2 resulted in relatively lower d(50) value compared to that 
of other formulations and more fines and higher SSA as well. In contrast, F3 with higher 
MAS content produced less fine particles with higher d(50) value. The observation in the 
particle size analysis indicated that the MAS/polymer ratios in the formulations had a mixed 
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effect while the amount of the binder present in the formulation compositions didn’t seem to 
have a significant effect on the particle size.  
Fig. 2b represents the topographic and phase images of the sample containing IBU, 
MAS, HPMC and PEG (F1 and F3). It is quite evident from the AFM images that there was 
no indication of the crystallisation of the drug on the surface of the granules. The topographic 
AFM image demonstrates the roughness of the surface due to the porosity of MAS present in 
the system or due to the manufacturing process. AFM also confirms the homogeneity of 
material with no indication of phase separation or evidence of crystalline material on the 
surface of the composite granules. 
SEM examined the surface morphology for both the bulk drug and the composite 
granules. As can be seen in Fig. 3a that the bulk crystalline IBU appeared as needle shaped 
crystals with average particle size about ~100 µm. In contrast, no drug crystals can be seen in 
the composite granules suggesting a possible adsorption in the porous MAS network (300 
m
2/g) and consequently particle size reduction of the drug substance through the granulation 
process. The composite granules appeared as agglomerates of micro-structured particle 
giving them a coarse shape. During the mechano-chemical processing, the drug particles may 
have been entrapped within the mesoporous silica network of the synthetic amorphous MAS 
used in the formulations. Similar results were found in one of our previously reported study 
[20]. Moreover, EDS analysis was performed to map the distribution of IBU and 
homogeneity of the composite granules [24, 25]. Both the drug and polymeric career used in 
this study mainly contain C and O atoms likewise most of the polymers. Since there was no 
unique signature atom present in the structure of IBU, it was expected that the elemental 
analysis of inorganic MAS will provide comprehensive analysis on the distribution of the 
excipients and perhaps the drug molecules on the surface of the composite granules. As can 
be seen in Fig. 3b, all elements unique to MAS (Al, Mg and Si) showed a homogenous 
distribution throughout all granules suggesting the homogeneity of the MAS all over the 
granules. Therefore, it can be assumed that the drug may have dispersed homogeneously 
likewise the MAS molecules.  
 
3.2 Solid state analysis 
The crystallinity of IBU in various manufactured composite granules was analyzed 
via XRPD.  As depicted in Fig. 4a, bulk drug exhibited distinct intense peaks corresponding 
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to its crystalline nature at various 2θ positions (mainly at 6.03o, 12.09o, 16.48o, 17.55o, 
18.75o, 20.02o, 22.13o, 24.47o and 24.99o 2θ positions). As expected, two characteristic 
intense peaks were visible in the diffractograms of bulk PEG at 19.01o and 23.49o 2θ 
positions [20]. Being completely amorphous in nature both MAS and HPMC revealed no 
intense peak in their respective diffractograms. All physical blends of formulations exhibited 
intense crystalline peaks due to the presence of crystalline drug and PEG which area identical 
to that of corresponding bulk substances. Similarly, the composite granules revealed an alike 
pattern of various peaks due to the presence of crystalline IBU but at relatively lower 
intensities. This is associated with the increase of amorphicity of the drug after the 
granulation process [20, 26]. This can also be attributed to the partial entrapment of the drug 
in the mesoporous network of the MAS [17, 20]. The calculation of the percentage 
crystallinity indicated that less than 15% of the crystalline drugs converted to its amorphous 
form during the high shear milling/granulations. In order to obtain and identify the amount of 
amorphous content present, the raw diffraction data were fitted to a standard diffractogram 
retrieved from the Cambridge Structural Database (CSD). The amorphous content was then 
calculated from the redistributed amount which is not associated to its crystalline counterpart 
[26].  
The crystalline state and the thermal profiles of the bulk drug in the manufactured 
composites were investigated via DSC. Supp. Fig. 1 shows the DSC traces of bulk substances 
physical blends of the drug/substances as well as the manufactured granules. The bulk IBU 
showed an endothermic thermal transition at 77.79oC (∆H = 92.99 j/g), which corresponds to 
its melting peak while PEG exhibited an endothermic sharp melting peak at 52.82oC (∆H = 
133.39oC). As seen in the XRPD diffractograms, due to being completely amorphous HPMC 
did not show any thermal transitions in its DSC trace. Likewise, amorphous MAS did neither 
show any thermal transitions due to its melting nor any glass transition (Tg). The reason for 
the latter being that the Tg of MAS is relatively higher and beyond our experimental heating 
segment (0-200oC). The DSC traces of the physical blends of both F1 and F2 formulations 
exhibited an endothermic thermal event at about 53-54oC due to the melting of PEG followed 
by a second endothermic peak at 77oC due to the melting of the drug (Fig. 4b). However, the 
DSC traces of the composite granules showed similar thermal transitions but slightly shifted 
to a lower temperature (61.79-67.29oC) due to the plasticisation effect of the low melting 
point PEG or the partial solubilisation of the drug in the PEG/MAS porous network. Similar 
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thermal behaviours of the crystalline drugs and substances were observed for F3 and F4 also 
(Supp. Fig 2). 
 
 
 
3.3 DVS analysis 
DVS analysis was implemented to assess the moisture absorption and desorption 
profile of all manufacture granules. The amount of water up-taken by various granules can be 
correlated to the physical solid state stability monitored by the DVS machine.  The presence 
of hydrophilic components such as HPMC and PEG along with the disintegration-promoting 
agent MAS may lead to an increased amount of water absorbed. As can be seen in Fig. 5, the 
water vapour sorption isotherms indicate increased amount of water uptake upon increasing 
the relative humidity (RH) at two different temperatures (ambient and 40oC). All 
formulations showed about 3-5% increase by weight at 60% RH in both 25oC and 40oC 
temperature. After then, a slight increase in the RH led to a relatively higher increase in mass 
of moisture. The final mass increase observed was about 13-15% by mass at 100% RH for all 
granules. Likewise, the absorption isotherms, the desorption isotherms of F1, F2 and F3 
presented a reversible process by showing a steady water loss profile. In contrast, F4 showed 
slightly different isotherms in terms of both the water uptake and water loss segments. At 
ambient, F4 showed no or very minimal mass gain as a function of the water uptake. In the 
desorption isotherms, there’s no further water loss but a steady almost straight line was 
observed. A similar phenomenon has previously been observed in one of our previous 
studies, where this steady straight line resulted in an open hysteresis [20, 27] due to 
recrystallization of IBU [28]. Moreover, the amount of PEG (15% w/w) and hydrophilic 
polymer present in formulation F4 may have affected this event.  Furthermore, the analysis of 
loss on drying (LoD) to a constant weight [20] indicated about 1.78-2.01 % (w/w) weight loss 
on drying were determined for all formulations (Table 1). This can be attributed to the loss of 
free water from the surface of the granules after keeping it in the oven at 60oC for 24 hours. 
Similar findings were reported in a previous study where an emerging twin-screw granulation 
extrusion approach was utilised [20].  It can be concluded from the DVS analysis that all 
composite granules seemed to be physically stable even in the presence of high content of 
granulating liquid (20 % w/w).  
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3.4 Electrostatic charge analysis 
Samples of F1, F2, F3 and F4 were tested to determine the bipolar charging properties 
using our optimised novel method [16, 23] as described above. Results are summarised in 
Table 2 and are also depicted in Fig. 6. The electrostatic charge distribution data presented in 
Fig. 6 shows that F1 and F2 acquire strong unipolar (negative) charge but F3 and F4 show 
bipolar charge behaviour where the net charge is very close to zero. These results indicated 
that the charge behaviour is changed upon changing the formulation composition especially 
MAS/polymer ratios. The charge behaviour of particulates changes very abruptly with the 
sample F1 and F2. This may be attributed to the complex nature of electrostatic charging in 
the mixture of material due to repeated particles tribocharging with the same and/or different 
species of particulate and with the equipment wall [16]. Interestingly, the particle size 
distribution seemed have influenced the type of charging behaviours of different 
formulations. F1, where HMPC/MAS ratio is 35/15, shows relatively less fines whereas F2 
with less HMPC in the formulation results in more fines (d10 = 2.27 µm). While comparing 
the charge distribution analysis (CMR), it seems F2 with higher fine particles showed a net 
negative charge while in contrast, F1 showed a net positive charge. The rest two formulations 
(F3 and F4) having relatively less amount of fines, revealed almost net neutral charge. 
However, it can be seen from this study that, the particle size distribution has a complex 
effect on the electrostatic charge of the formulations. A slight deviation in sample handling 
during the down-stream processing may have influenced the results. As reported by Adebisi 
et al., (2016), during the grinding process, electrons can be transferred from the stainless steel 
surface to the negatively charged powder particles and thus have an effect on the nature of 
both the charge density and charge distribution analysis [23]. Despite having variable results, 
the electrostatic charging didn’t have significant negative effect in terms of the flowability of 
the particles.  The Carr’s index calculation showed a value of about 11-15.50 indicating that 
all composite granules have good flow properties.  
3.5 In vitro dissolution studies 
The main objective of this study was to evaluate the effect of the manufacturing 
process and formulation composition on the enhancement of the release rates of the 
hydrophobic IBU. The in vitro release profiles of all manufactured composite granules are 
depicted in Fig. 7 where it can be seen that all composite granules showed increased 
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dissolution rates of IBU varying from 65-90% within 2 h which fully comply with the USP 
monograph [29]. In contrast, the bulk drug showed only about ~ 20% release after 2 h. 
Interestingly, F3 and F4 seemed the best where about 90% drug has been released in 2 h, 
which is about 5 fold increase compared to the bulk IBU release. In contrast, F1 and F2 
showed slightly lower release compared to the other two formulations. Also, as can be seen in 
Supp. Fig 3, all of the manufactured formulations showed higher release rates of IBU 
compared to that of their respective physical mixtures (PM). Since XRPD analysis revealed a 
slight increase in the amorphicity of IBU in the granules, this may have contributed to the 
increase in the dissolution rates. Moreover, the mechanochemical granulation approach may 
have facilitated the drug being adsorbed within the inorganic porous network of mesoporous 
synthetic MAS and the particle size reduction thereafter.  In addition, faster dissolution rates 
were observed for F3 and F4, those granulated formulations with the high specific surface 
area (0.6 - 0.7m2/g), which is directly interrelated to the porosity of the granules.  It has been 
reported elsewhere that dissolution properties were significantly affected by the porosity 
change of the granules resulting in a faster hydration and thus the water sorption/penetration 
[26, 30]. Nonetheless, the composition of the formulations have also played a pivotal role in 
the dissolution behaviour of IBU from various composite granules. For the same reason, F4 
outperforming all other formulations may have been associated with the increased amount of 
PEG in the formulations. 
 
4. Conclusions 
IBU loaded semi-crystalline granules have successfully been manufactured via a 
mechano-chemical granulation approach. Both DSC and XRPD revealed a semi-crystalline 
form of IBU in the composite granules which may have had an effect on dissolution rates of 
the drug. Moreover, the surface analysis and particle morphology conducted via SEM/EDS 
and AFM revealed a homogenous distribution of the drug in all composite granules. The 
unique composition of the formulation in the presence of the synthetic inorganic MAS eased 
the optimization of the granules. The electrostatic charging determined via a novel approach 
of triboelectrification revealed a variable charge distribution of the granules. Furthermore, all 
composite granules demonstrated a substantial enhancement in the in vitro dissolution rate of 
the drug. This evolving mechanochemical processing technology can be adopted and 
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implemented for a wide range of poorly water soluble drugs in order to enhance its 
dissolution rates. 
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TABLES 
 
Table 1: Formulation compositions of IBU (40% w/w) loaded composite granules 
Formulation HPMC/MAS 
(% w/w) 
PEG 
(% 
w/w) 
d(10) 
(µm) 
d(50) 
(µm) 
d(90) 
(µm) 
Span 
 
SSA 
(m2/g) 
LoD 
(%) 
IBU  25.20 70.10 195.10 2.43  
F1 35/15 10 35.13 150.00 265.10 2.6 0.09 1.78 
F2 25/25 10 2.27 97.10 286.40 3.3 0.10 1.80 
F3 15/35 10 54.15 140.60 258.40 1.5 0.06 2.01 
F4 25/20 15 42.61 125.10 246.60 1.6 0.07 1.57 
 
Table 2: Electrostatic charge to mass ratio (CMR) determined via triboelectrification method 
of all composite granules 
 
Charge to Mass Ratio (CMR) 
nC/g Standard Deviation 
Positive 
CMR 
Negative 
CMR 
Net 
CMR 
Positive 
CMR 
Negative 
CMR 
Net 
CMR 
F1 3.63 -0.02 3.60 0.21 0.03 0.18 
F2 0.02 -2.42 -2.40 0.02 0.34 0.35 
F3 0.40 -0.54 -0.14 0.19 0.13 0.06 
F4 0.64 -0.36 0.28 0.17 0.08 0.16 
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Figures caption list 
Fig. 1 (a) Schematic overview of entire test facility, (b) typical charge signal 
obtained as a result of samples F3 passing through the sensor 
Fig. 2 (a) Particle size distribution of different IBU granules, (b) AFM (left-
topography) and (right-phase) images of IBU loaded composite granules 
of F1 (HPMC/MAS: 35/15) and F3 (HMPC/MAS: 15/35).  
Fig. 3 (a) SEM images of bulk drug and the composite granules, (b) EDS 
elemental analysis of the composite granules. 
Fig. 4 (a) X-ray diffractograms of bulk substances and the granules, (b) DSC 
thermal transitions of the physical mixtures (PM) and the manufactured 
granules of F1 and F2. 
Fig. 5 DVS sorption/desorption curve of IBU loaded semi-crystalline granules 
(F1-F4) 
Fig. 6 Charge to mass ratio (CMR) of different composite granules (F1-F4), P-
CMR and N-CMR denote positive and negative CMR, respectively.   
Fig. 7 In vitro dissolution profiles of bulk IBU and manufacture semi-
crystalline granules (F1-F4). 
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Highlights: 
 
• Mechano-chemical process is efficient to manufacture semi-crystalline 
granules  
• Produced composite granules showed enhanced dissolution rates 
• The electrostatic charging has a significant effect on the granule properties 
• Surface morphology plays a pivotal role to develop stable composite granules 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
